AMLX Latest Headlines

Amylyx (AMLX) sets Sept. 30 fireside chat at Stifel 2026 Virtual Cardiometabolic Forum

Market Chameleon (Wed, 23-Sep 9:46 AM)

Amylyx Upsizes to $500 Million Public Offering: Targeting Pipeline Growth and Avexitide Launch

Market Chameleon (Thu, 20-Aug 8:14 AM)

Amylyx Eyes Major Capital Raise: $350 Million Public Offering Targets Growth and Pipeline Progress

Market Chameleon (Wed, 19-Aug 10:31 AM)

AMLX Surges as Amylyx Sets Date for Phase 3 Results: What Does the 2026 LUCIDITY Readout Mean for Investors?

Market Chameleon (Tue, 18-Aug 10:29 AM)

Avexitide Delivers 55% Reduction in Severe Hypoglycemic Events: Amylyx Phase 3 LUCIDITY Results Set Stage for First FDA-Approved PBH Therapy

Market Chameleon (Tue, 18-Aug 7:05 AM)